Skip to main content

Table 4 Adjusted effect estimates (aOR CI 95%) for associations with RC, allergic RC and non-allergic RC at 14 years of age

From: Early childhood risk factors for rhinoconjunctivitis in adolescence: a prospective birth cohort study

  RC RC inc. s-IgE ≥ 4.00 SU/ml Allergic RC Allergic RC inc s-IgE ≥ 4.00 SU/ml Non-allergic RC
aOR (CI 95%) aOR (CI 95%) aOR (CI 95%) aOR (CI 95%) aOR (CI 95%)
Gender 1.26 (0.78–2.04) 1.30 (0.80–2.12) 1.90 (1.06–3.41)* 2.08 (1.14–3.81)* 0.64 (0.31–1.32)
FH 2.01 (1.25–3.23)* 2.01 (1.24–3.26)* 2.25 (1.27–3.99)* 2.32 (1.28–4.18)* 1.45 (0.72–2.92)
Early sensitization to inhalant allergens 1.31 (0.78–2.20)   1.65 (0.91–3.02)   NI
Early sensitization to foods 1.62 (0.99–2.67)*   1.57 (0.86–2.87)   NI
s-IgE ≥ 4.00 SU/ml to inhalant allergens   2.03 (1.06–3.90)*   2.92 (1.43–5.96)* NI
s-IgE ≥ 4.00 SU/ml to food allergens   2.38 (1.15–4.93)*   3.13 (1.41–6.95)* NI
FA 3.49 (1.00–12.16) 2.36 (0.62–8.92) 3.89 (1.08–14.08)* 2.08 (0.52–8.31) NI
AD 2.44 (1.37–4.33)* 2.11 (1.17–3.81)* 3.24 (1.72–6.12)* 2.68 (1.38–5.19)* NI
ETS 0.42 (0.26–0.69)* 0.42 (0.26–0.69)* 0.47 (0.26–0.83)* 0.48 (0.27–0.87)* 0.43 (0.20–0.92)*
Maternal tobacco smoking in pregnancy NI NI NI NI 0.56 (0.21–1.46)
Older siblings 0.64 (0.40–1.03) 0.66 (0.41–1.07) 0.53 (0.30–0.94)* 0.55 (0.31–1.00)  
  1. NI not included due to univariate logistic regression analysis
  2. P ≤ 0.05